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REPLY
We appreciate the interest by Drs. Henrikson and Chandra-
Strobos in our recent study (1). They disagree with the
conclusion that lower levels of troponin are likely analytical
false positives and are more likely related to necrosis. This is
based on the results of their recent study (2), in which
patients with minor troponin T (TnT) elevations had a
higher event than those without detectable levels, and were
closer to those with clearly elevated levels (2).
However, the two studies are not directly comparable.
The range of TnT levels, which they called “marginal”
(defined as levels between 0.01 ng/ml and 0.09 ng/ml), was
fairly broad. The TnT levels from 0.01 to 0.03 ng/ml
(between the lower limit of detectability and 10% coefficient
of variation [CV]) (3) are equivalent to our low troponin I
values, whereas those from 0.03 to 0.09 ng/ml (from the
10% CV to the prior myocardial infarction [MI] diagnostic
criteria) would be equivalent to our intermediate TnI levels.
The fact that their marginal TnT values are a combination
of low and intermediate TnT values likely explains the
higher event rate that was found. For example, the propor-
tion of patients who had elevated creatine kinase-MB
fraction (CK-MB) was 15% in our TnI intermediate group,
comparable to 14% in their marginal TnT group; in
contrast, only 1.1% of patients in our TnI low group had
increased CK-MB.
In addition, we did not call patients with detectable TnI
values “normal.” We made the distinction between low
elevations, in which some represent necrosis; this is seen by
the higher event rate. However, as we and others have noted
(4), this is a mixture of a small number of patients who truly
have necrosis and a much higher number who have analyt-
ical false positives. As we noted, labeling a patient who has
atypical chest pain, no-ischemic electrocardiographic
changes, low levels of CK-MB not near the diagnostic
cut-off, and with minor troponin elevations as having an
myocardial infarction has significant implications for the
patient’s long-term health care, and we believe this is
inappropriate. As none of the currently available assays
conform to recommended standards (5), our data, as well as
other recommendations (6), are that these values may be
indicative of necrosis, and therefore should be further
evaluated. This evaluation should be dependent on the
clinical scenario. Rather than routinely performing coronary
angiography as recommended by the American College of
Cardiology/American Heart Association guidelines for pa-
tients who have troponin elevations, we believe that stress
testing would be an appropriate evaluation, for many of
these patients.
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The Diet–Heart Hypothesis:
An Evolutionary Support
Nothing in biology makes sense except in the light of evolution.
Theodosius Dobzhansky, 1973
Considering that humankind and its metabolic physiology
are biological products of evolution, one might well ask why
Weinberg’s report (1) not only ignores the evolutionary
arguments supporting the diet–heart hypothesis, but also
advances the evolutionarily untenable thesis that the low-
fat, high-carbohydrate diet is responsible for the current
epidemics of obesity, type II diabetes, and the metabolic
syndrome.
Weinberg seems to forget that the low-fat, high-
carbohydrate diet represents the diet “for which human
beings are in essence genetically programmed” (2), because
their metabolic physiology has been evolutionarily molded
by a nutritional environment in which, for millions of years,
that diet was practically the sole one available to our
ancestors (3). For 99% of its evolution, humankind indeed
lived mainly on fruits and vegetables, which consist essen-
tially of carbohydrates, and consumed little fat, because
game was very lean and cattle-breeding, chicken farming,
butter, dairy products, margarines, and oils did not exist (2).
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Weinberg fails to note that coronary heart disease and
type II diabetes were virtually absent in some traditional
populations that ate mainly carbohydrates and consumed
two to three or even five times less fat than Westerners (2).
As evidence that the diet–heart hypothesis is correct, those
populations, after their switch to Western diets, are cur-
rently facing epidemics of cardiovascular disease (2), type II
diabetes (2,3), and obesity (3).
Weinberg also fails to note that in rural China, where
dietary energy derives mostly from carbohydrates and the
consumption of fat is less than one-half that of Americans,
coronary artery disease mortality is 16.7-fold lower than that
in the U.S. (3). As an additional support of the diet–heart
hypothesis, in urban China the proportion of cardiovascular
disease deaths rose from 12.1% in 1957 to 35.8% in 1990
because of the greatly increased fat consumption, favored by
the global availability of cheap vegetable oils (2).
Weinberg’s critique of the diet–heart hypothesis is based
on the misleading results of dietary trials, most of which
investigated the effects of diets that were called “low-fat”
inappropriately. As a paradigmatic example, if we consider
that diets exceeding 10% to 15% of energy as fat were
virtually impossible in the low-fat nutritional environment
that shaped our metabolic physiology (3), the expression
“low fat” is inappropriate to define a diet providing 31% of
energy as fat (4). The beneficial effects of an evolutionarily
defined low-fat diet providing only 10% of energy as fat are
unquestionable (5).
Weinberg argues that low-fat, high-carbohydrate diets
are unhealthy because they decrease high-density lipopro-
tein (HDL) cholesterol and increase triglycerides. However,
populations that consume mostly carbohydrates, despite
having low HDL cholesterol, are virtually free from coro-
nary heart disease (2). Moreover, the low-fat, high-
carbohydrate diet, instead of increasing triglycerides, may
actually reduce them, as long as sugar intake is kept low (5),
to limit the harmful effects caused by sugars consumed in
solid forms or in solutions exceeding the physiologic limit
imposed by evolution, namely 4.18 MJ/l (3).
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REPLY
In his discussion of my commentary on the diet–heart
hypothesis (1), Dr. Baschetti suggests that the low-fat,
high-carbohydrate diet is the diet “for which human beings
are in essence genetically programmed, because their met-
abolic physiology has been evolutionarily molded by a
nutritional environment in which, for millions of years, that
diet was practically the sole one available to our ancestors.”
However, the references he cites for documentation are
merely similar letters to editors in which he previously
expressed the same opinions, a practice he has pursued
beyond those cited here (2). I would point out to Dr.
Baschetti that my conclusions about the role of the low-fat,
high-carbohydrate diet in the current epidemics of obesity,
type II diabetes, and metabolic syndrome are based on what
has actually occurred in the U. S. and elsewhere over the last
three or more decades. In my critique, I also cited several
recent randomized trials in which low-carbohydrate, high-
protein diets showed improvement in lipid patterns, insulin
sensitivity, and weight loss, compared with low-fat, high-
carbohydrate diets. Although Dr. Baschetti dismisses these
studies as “misleading” they are well-controlled trials at
highly regarded institutions, and they were performed by
scientists who were highly circumspect in self-appraisal of
their work.
Dr. Baschetti also argues, as he did in his cited letter to
Dr. M. B. Katan (3), that rural Chinese on low-fat,
high-carbohydrate regimens have less coronary disease than
occurs in the U. S., although it is rising as fat intake
increases. Dr. Baschetti cites this as further evidence favor-
ing the low-fat, high-carbohydrate diet. I respond as did Dr.
Katan (3), that there are many other factors which make
comparison of rural Chinese with American populations
difficult, including rising use of cigarettes in China, different
levels of physical activity, and of sanitation, health care, and
the types of fats available to the low-income Chinese, such
as tropical oils, high in saturated fat.
Further, to advocate a low-fat, high-carbohydrate diet
because that was the diet primitive peoples ate millions of
years ago and to claim that we, therefore, are genetically
endowed for that to be the ideal diet, and beyond that to
disregard the negative experience with the low-fat, high-
carbohydrate diet on the U.S. and other populations and to
reject as “misleading” positive randomized research data
favoring the low-carbohydrate, high-protein diet, seems
fanciful indeed.
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